Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron and Granisetron for Treatment of Obsessive-Compulsive Disorder
IRCT20130726014170N2Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ondansetron and granisetron in obsessive compulsive disorder (OCD), sponsored by Arak University of Medical Sciences. Started Dec 2014; status: completed.
02
Drugs
ondansetrongranisetron
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on IRCT20130726014170N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130726014170N2.